Combination chemotherapy with Regorafenib in metastatic colorectal cancer treatment: A single center, retrospective study

BACKGROUND: Regorafenib has been demonstrated as effective in refractory metastatic colorectal cancer. Combination use with chemotherapy has not been reported. We examined the efficacy and safety of adding chemotherapy to Regorafenib for the treatment of metastatic colorectal cancer(mCRC) patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Chun-Yu, Lin, Tseng-Hsi, Chen, Chou-Chen, Chen, Ming-Cheng, Chen, Chou-Pin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5755875/
https://www.ncbi.nlm.nih.gov/pubmed/29304109
http://dx.doi.org/10.1371/journal.pone.0190497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5755875/
https://www.ncbi.nlm.nih.gov/pubmed/29304109
http://dx.doi.org/10.1371/journal.pone.0190497

Ejemplares similares